Record overview
Status and phase
Status: TERMINATED
Phase: PHASE2
Sponsor: Melissa Burgess, MD
Condition: Active Melanoma Brain Metastases
NCT02230306
Phase II Study of Cobimetinib in Combination With Vemurafenib in Active Melanoma Brain Metastases
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
closed due to slow accrual